Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial
Charalampia Amerikanou, Stavroula Kanoni, Andriana C. Kaliora, et al.
Molecular Nutrition & Food Research (2021) Vol. 65, Iss. 10
Open Access | Times Cited: 25

Showing 25 citing articles:

Triterpenoids from Chios Mastiha Resin Against MASLD—A Molecular Docking Survey
Nаtаsа Мilоsеvic, Maja Milanović, Milica Medic‐Stojanoska, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 51-51
Open Access | Times Cited: 1
Evaluating Bioactive-Substance-Based Interventions for Adults with MASLD: Results from a Systematic Scoping Review
Deepa Handu, Kim S. Stote, Tami A. Piemonte
Nutrients (2025) Vol. 17, Iss. 3, pp. 453-453
Open Access | Times Cited: 1
What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
Marcin Kosmalski, Rafał Frankowski, Sylwia Ziółkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1852-1852
Open Access | Times Cited: 22
Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
Paweł Rajewski, Jakub Cieściński, Piotr Rajewski, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 217-217
Open Access
Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action
Charalampia Amerikanou, Efstathia Papada, Aristea Gioxari, et al.
Pharmacological Research (2021) Vol. 171, pp. 105753-105753
Open Access | Times Cited: 28
Effects of Non-Polar Dietary and Endogenous Lipids on Gut Microbiota Alterations: The Role of Lipidomics
Konstantinos Tsiantas, Spyridon J. Konteles, Eftichia Kritsi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4070-4070
Open Access | Times Cited: 19
Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis
Nan Yao, Yixue Yang, Xiaotong Li, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 19
Chios mastiha essential oil exhibits antihypertensive, hypolipidemic and anti-obesity effects in metabolically unhealthy adults - a randomized controlled trial
Aristea Gioxari, Charalampia Amerikanou, Evdokia Valsamidou, et al.
Pharmacological Research (2023) Vol. 194, pp. 106821-106821
Open Access | Times Cited: 12
Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
Manuela Vitulo, Elisa Gnodi, Giulia Rosini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12748-12748
Open Access | Times Cited: 11
Efficacy of Pistacia lentiscus Plant (Rumi Mastagi) in Comparison to Levosulpiride in Patients with Diabetic Gastroparesis: A Double-Blind Non-Inferior Randomised Control Trial Study
Ajaypal Singh, Ravi Kant, Rohit Raina, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 1, pp. 35-42
Open Access | Times Cited: 3
Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD
Stavroula Kanoni, Satish Kumar, Charalampia Amerikanou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 22
Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds
Marcin Kosmalski, Rafał Frankowski, Kacper Deska, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2838-2838
Open Access | Times Cited: 7
Topical treatment with mastic (resin from Pistacia lentiscus) elicits anti-inflammatory and anti-pruritic responses by modulating keratinocyte activation in a mouse model of allergic dermatitis
Risako Kishimoto, Narumi Kato, Mayuka Koike, et al.
Phytomedicine (2021) Vol. 91, pp. 153679-153679
Closed Access | Times Cited: 14
Interventions for non-alcoholic liver disease: a gut microbial metabolites perspective
Jin Guo, Chunxia Shi, Qingqi Zhang, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 8
Chios Mastic Gum: A Promising Phytotherapeutic for Cardiometabolic Health
Sarah A. Blomquist, María Luz Fernández
Nutrients (2024) Vol. 16, Iss. 17, pp. 2941-2941
Open Access | Times Cited: 1
Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
Mingmei Shao, Yifei Lü, Hongjiao Xiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease
José Ignacio Martínez‐Montoro, Isabel Cornejo‐Pareja, Ana María Gómez Pérez, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 4077-4077
Open Access | Times Cited: 8
Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study
Athina I. Amanatidou, Andriana C. Kaliora, Charalampia Amerikanou, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 2, pp. 971-971
Open Access | Times Cited: 4
Plasma Amino Acids in NAFLD Patients With Obesity Are Associated With Steatosis and Fibrosis; Results From the MAST4HEALTH Study
Athina I. Amanatidou, Eleni V. Mikropoulou, Charalampia Amerikanou, et al.
(2023)
Open Access | Times Cited: 2
Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study
Athina I. Amanatidou, Eleni V. Mikropoulou, Charalampia Amerikanou, et al.
Metabolites (2023) Vol. 13, Iss. 8, pp. 959-959
Open Access | Times Cited: 2
Real-world safety and effectiveness of Pistacia lentiscus (mastic gum) in patients with diabetic gastroparesis: 24-week interim analysis postintervention
Ravi Kant, Ajaypal Singh, Rohit Raina, et al.
Indian Journal of Pharmacology (2024) Vol. 56, Iss. 1, pp. 4-9
Open Access
Investigation of Antihypertensive Properties of Chios Mastic via Monitoring microRNA-21 Expression Levels in the Plasma of Well-Controlled Hypertensive Patients
Maria Tsota, Tota Giardoglou, E. Nikolaou, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 3, pp. 33-33
Open Access
Phytochemical investigation of Pistacia lentiscus L. var. Chia leaves: A byproduct with antimicrobial potential
Christodoulos Anagnostou, Stavros Beteinakis, A Papachristodoulou, et al.
Fitoterapia (2023) Vol. 170, pp. 105648-105648
Closed Access | Times Cited: 1
MRI in liver cirrhosis
Osama Alzoubi, Ahmad Arar, Viraj Singh, et al.
Portal hypertension & cirrhosis (2022) Vol. 1, Iss. 1, pp. 23-41
Open Access | Times Cited: 2
The 10th Santorini conference: Systems medicine, personalised health and therapy. “The odyssey from hope to practice: Patient first. Keep Ithaca always in your mind”, Santorini, Greece, 23–26 May 2022
Sophie Visvikis‐Siest, Maria G. Stathopoulou, Raute Sunder‐Plaßmann, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access
Page 1

Scroll to top